1-chloroethyl-2-cyclohexylacetate | 84674-30-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-chloroethyl-2-cyclohexylacetate
• 英文别名: 1-Chloroethyl 2-cyclohexylacetate
• CAS: 84674-30-6
• 化学式: C₁₀H₁₇ClO₂
• 分子量: 204.697
• InChiKey: DHUHSGBKWBWOHB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  乙醛 、 环己基乙酰氯 在 氯化锌 作用下， 以83.7%的产率得到1-chloroethyl-2-cyclohexylacetate
  参考文献：
  名称：

  Method for producing 1-iodoalkyl acylates

  摘要：

  一种1-碘烷基酰酸酯，可用作头孢菌素、青霉素等酯化反应的原料，通过以下方式制备：（1）使羧酸碘化物与醛反应，或（2）使羧酸氯化物与碘化氢盐反应，然后使生成的产物与醛反应，或（3）同时使羧酸氯化物、碘化氢盐和醛相互反应，以高纯度和高产率制备。

  公开号：

  US04593115A1

文献信息

• Cephalosporin esters
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0109294A2

  公开（公告）日：1984-05-23

  A compound of the formula wherein m is an integer of 0 or 1; n is an integer of 2 to 5, inclusive, or its pharmaceutically acceptable salt, which is effective as orally administrable antibiotic agents against both gram-positive- and -negative-bacteria, and the production and compositions thereof, are proposed.

  一种式子为 其中 m 为 0 或 1 的整数；n 为 2 至 5（含）的整数，或其药学上可接受的盐，作为口服抗生素制剂对革兰氏阳性菌和阴性菌均有效。
• Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them
  申请人：SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD.

  公开号：EP0415566A1

  公开（公告）日：1991-03-06

  Novel heterocyclic compounds capable of lowenng the und acid levels in plasma and unne having the formula (I) wherein R2 and R2 are independently hydrogen, lower alkyl, phenyl or substituted phenyl, or R' and R2 may form a four to eight-membered carbon ring together with the carbon atom to which they are attached: R3is hydrogen or lower alkyl: R4 is one or two radicals selected from a group consisting of hydrogen, halogen, nitro. lower alkyl. phenyl. substituted phenyl, -OR5 and -SO2NR6R6; R5 is hydrogen. lower alkyl phenyl-substituted lower alkyl. carboxymethyl or ester thereof, hydroxethyl or ether thereof, or allyl; R6 and R6 are independently hydrogen or lower alkyl: R7 is hydrogen or a pharmaceutically active ester-forming group: A is a straight or branched hydrocarbon radical having one to five carbon atoms: B is halogen. oxygen, or dithiolane; Y is oxygen. sulfur, nitrogen or substituted nitrogen; Z is oxygen, nitrogen or substituted nitrogen: dotted line represents the presence or absence of a single bond, processes for their production and pharmaceutical compositions comprising them.

  能降低血浆和ne中und酸含量的新型杂环化合物，其式为(I) 其中 R2 和 R2 独立地为氢、低级烷基、苯基或取代苯基，或 R' 和 R2 可与所连接的碳原子一起形成四至八元碳环：R3 是氢或低级烷基：R4是一个或两个基团，选自由氢、卤素、硝基、低级烷基、苯基、取代苯基、-OR5和-SO2NR6R6组成的组；R5是氢、低级烷基苯基取代低级烷基、羧甲基或其酯、羟乙基或其醚或烯丙基；R6和R6独立地是氢或低级烷基：R7 是氢或药用活性酯形成基团：A 是具有 1 至 5 个碳原子的直链或支链烃基：B是卤素、氧或二硫环烷；Y是氧、硫、氮或取代的氮；Z是氧、氮或取代的氮：虚线表示存在或不存在单键，其生产工艺和包含它们的药物组合物。
• US4593115A
  申请人：——

  公开号：US4593115A

  公开（公告）日：1986-06-03
• US5268386A
  申请人：——

  公开号：US5268386A

  公开（公告）日：1993-12-07
• Method for producing 1-iodoalkyl acylates
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US04593115A1

  公开（公告）日：1986-06-03

  An 1-Iodoalkyl acylate, which is useful as the raw material for esterification of cephalosporins, penicillins, etc. is prepared in a high degree of purity and in high yield by (1) allowing a carboxylic acid iodide to react with an aldehyde, or (2) allowing a carboxylic acid chloride to react with a salt of hydriodic acid and then allowing the resulting product to react with an aldehyde, or (3) by simultaneously allowing a carboxylic acid chloride, a salt of hydriodic acid and an aldehyde to react with one another.

  一种1-碘烷基酰酸酯，可用作头孢菌素、青霉素等酯化反应的原料，通过以下方式制备：（1）使羧酸碘化物与醛反应，或（2）使羧酸氯化物与碘化氢盐反应，然后使生成的产物与醛反应，或（3）同时使羧酸氯化物、碘化氢盐和醛相互反应，以高纯度和高产率制备。